Discusses the announcement by Harold Varmus of a compromise on the future of the National Institutes of Health's (NIH) Recombinant DNA Advisory Committee (RAC). Varmus' role as director of the NIH; His original plan to abolish the RAC; The responsibilities being given to the US Food and Drug Administration (FDA); The response of scientists affected by the decision.